CD38 and neoplasm: Moreover, they observed an objective remission of MM in 100% of mice treated with doses ranging from 800 to 1,200 μCi of anti-CD38 pre-targeted (90)Y-DOTA-biotin 7 days after the treatment, with a complete remission at day 23, with undetectable tumor masses.